This is in agreement with a study of a pan-cancer cohort across 20 different cancer types, including ovarian cancer, in which only 2 patients out of the 1200 analyzed harbored both a PIK3R1 and a PIK3CA mutation [45]. This evidence concerns the gene PIK3CA and ovarian carcinoma.